Glass House Brands (GLAS) Income from Continuing Operations (2020 - 2026)

Glass House Brands' (GLAS) quarterly Income from Continuing Operations came in at 17006000.0 in Q1 2026, down 9.72% on a QoQ basis from 15500000.0 in Q4 2025.

Glass House Brands (GLAS) Income from Continuing Operations (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Income from Continuing Operations data on file, last reported at 17006000.0 in Q1 2026.

  • On a quarterly basis, Income from Continuing Operations changed N/A year-over-year to 17006000.0 in Q1 2026; TTM through Mar 2026 was 35950000.0, a N/A change from a year earlier, with the FY2025 full-year figure at 28952000.0, down 4115.53% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 17006000.0, down from 15500000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for GLAS reached as high as 15168550.0 in Q3 2022 and fell as low as 19659403246000.0 in Q2 2023.
  • Historically, Income from Continuing Operations has averaged 2470690482803.85 across 5 years, with a median of 17006000.0 in 2026.
  • Across the five-year window, Income from Continuing Operations soared 100.0% in 2022 and plunged 58.76% in 2023, its largest moves.
  • Year by year, Income from Continuing Operations stood at 28419588.0 in 2022, then plunged by 49.89% to 42597206.0 in 2023, then soared by 123.57% to 10039000.0 in 2024, then tumbled by 254.4% to 15500000.0 in 2025, then fell by 9.72% to 17006000.0 in 2026.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were 17006000.0 in Q1 2026, 15500000.0 in Q4 2025, and 12188000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 370.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -3.58 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 274.90 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 57.00 Mn
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn -17.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -17.01 Mn
Dec 31, 2025 -15.50 Mn
Sep 30, 2025 -12.19 Mn
Jun 30, 2025 8.74 Mn
Jun 30, 2024 10.04 Mn
Dec 31, 2023 -42.60 Mn
Sep 30, 2023 6.28 Mn
Jun 30, 2023 -19,659.40 Bn
Mar 31, 2023 -32.41 Mn
Dec 31, 2022 -28.42 Mn
Sep 30, 2022 15.17 Mn
Jun 30, 2022 -12,459.44 Bn
Mar 31, 2022 -20.41 Mn
Dec 31, 2021 -18.99 Mn
Sep 30, 2021 -6,955.68 Bn
Jun 30, 2021 -13,606.55 Bn
Mar 31, 2021 -13.15 Mn
Dec 31, 2020 -6.04 Mn
Sep 30, 2020 -1.15 Mn
Mar 31, 2020 -5.14 Mn